Schrodinger (NASDAQ:SDGR – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.81) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.25), FiscalAI reports. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The firm had revenue of $58.59 million during the quarter, compared to the consensus estimate of $47.57 million.
Schrodinger Trading Down 0.2%
Shares of NASDAQ SDGR traded down $0.03 during trading hours on Tuesday, hitting $12.87. 1,496,343 shares of the company traded hands, compared to its average volume of 1,379,425. The stock has a market capitalization of $950.13 million, a price-to-earnings ratio of -9.06 and a beta of 1.57. The company’s 50 day moving average price is $11.99 and its 200 day moving average price is $15.46. Schrodinger has a 12 month low of $10.94 and a 12 month high of $27.63.
Insider Buying and Selling at Schrodinger
In other news, CEO Ramy Farid sold 43,000 shares of the business’s stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $12.33, for a total transaction of $530,190.00. Following the transaction, the chief executive officer owned 330,824 shares of the company’s stock, valued at approximately $4,079,059.92. The trade was a 11.50% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 59,184 shares of company stock worth $741,556. Insiders own 21.00% of the company’s stock.
Hedge Funds Weigh In On Schrodinger
Analyst Ratings Changes
SDGR has been the topic of a number of research reports. Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, January 31st. TD Cowen reaffirmed a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. UBS Group reduced their price objective on Schrodinger from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. Finally, KeyCorp reduced their price objective on Schrodinger from $25.00 to $20.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $20.50.
Check Out Our Latest Analysis on SDGR
About Schrodinger
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Recommended Stories
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
